A Matrix Metalloproteinase 1-Cleavable Composite Peptide Derived From Transforming Growth Factor β-Inducible Gene h3 Potently Inhibits Collagen-Induced Arthritis

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide

(2012) Sarah E Wythe et al.   ANNALS OF THE RHEUMATIC DISEASES

Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe

(2011) Ju Hee Ryu et al.   ARTHRITIS AND RHEUMATISM

Matrix metalloproteinase-1 contribution to sarcoma cell invasion

(2011) Nandor Garamszegi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Drug targeting systems for inflammatory disease: One for all, all for one

(2011) Bart J. Crielaard et al.   JOURNAL OF CONTROLLED RELEASE

Transforming growth factor- -induced protein (TGFBIp/  ig-h3) activates platelets and promotes thrombogenesis

(2009) H.-J. Kim et al.   BLOOD

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

(2009) Kathrin Schwager et al.   ARTHRITIS RESEARCH & THERAPY

Transforming growth factor-β-induced gene product, as a novel ligand of integrin αMβ2, promotes monocytes adhesion, migration and chemotaxis

(2007) Ha-Jeong Kim et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY